What type of study is this?

This is a Meta-Analysis study (also classified as: Systematic Review).

December 8, 2025BloodOpen Access

Outcomes with repeat CAR-t cell therapy: A systematic review and meta-analysis

View Full Paper

Ask AI

Bookmark

Authors

Meta-analysis reports a 55% overall response in patients receiving repeat CAR-T therapy, indicating ongoing need for effective treatments.

Repeat CAR-T therapy achieved an overall response rate of 55%, showing potential for relapsed cases.
Patients included evaluations from three retrospective studies and one Phase I trial, indicating a comprehensive analysis approach.
Statistical analyses employed both random and fixed effects models, providing detailed insights into response rates and outcomes.
Generally, CART2 yielded lower response rates compared to CART1, highlighting the need for further research and trials.

Aman Ullah (2025) studied this question.

View Full Paper

Ask AI

Bookmark

December 8, 2025BloodOpen Access

View Full Paper

Ask AI

Bookmark

Authors

Meta-analysis reports a 55% overall response in patients receiving repeat CAR-T therapy, indicating ongoing need for effective treatments.

Repeat CAR-T therapy achieved an overall response rate of 55%, showing potential for relapsed cases.
Patients included evaluations from three retrospective studies and one Phase I trial, indicating a comprehensive analysis approach.
Statistical analyses employed both random and fixed effects models, providing detailed insights into response rates and outcomes.
Generally, CART2 yielded lower response rates compared to CART1, highlighting the need for further research and trials.

Aman Ullah (2025) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark